Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.57M | 24.56M | 24.99M | 26.56M | 27.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.33M | 60.94M | 65.17M | 69.34M | 76.72M |
| Operating Income | -54.33M | -60.94M | -65.17M | -69.34M | -76.72M |
| Income Before Tax | -56.86M | -63.46M | -64.77M | -68.80M | -76.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -56.86 | -63.46 | -64.77 | -68.80 | -76.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -56.86M | -63.46M | -64.77M | -68.80M | -76.57M |
| EBIT | -54.33M | -60.94M | -65.17M | -69.34M | -76.72M |
| EBITDA | -52.49M | -58.46M | -62.09M | -66.17M | -73.35M |
| EPS Basic | -18.30 | -20.43 | -21.40 | -23.40 | -27.03 |
| Normalized Basic EPS | -9.94 | -11.18 | -12.32 | -13.56 | -15.58 |
| EPS Diluted | -18.30 | -20.43 | -21.40 | -23.40 | -27.03 |
| Normalized Diluted EPS | -9.94 | -11.18 | -12.32 | -13.56 | -15.58 |
| Average Basic Shares Outstanding | 12.46M | 12.43M | 12.14M | 11.79M | 11.44M |
| Average Diluted Shares Outstanding | 12.46M | 12.43M | 12.14M | 11.79M | 11.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |